Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows.
Jain T, Prinz B, Marker A, Michel A, Reichel K, Czepczor V, Klieber S, Sun W, Kathuria S, Oezguer Bruederle S, Lange C, Wahl L, Starr C, Masiero A, Avery L.
Jain T, et al. Among authors: prinz b.
MAbs. 2024 Jan-Dec;16(1):2384104. doi: 10.1080/19420862.2024.2384104. Epub 2024 Jul 31.
MAbs. 2024.
PMID: 39083118
Free PMC article.